跳到主要导航 跳到搜索 跳到主要内容

Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality

  • Yahui Fan
  • , Mingxu Wang
  • , Zhaofang Li
  • , Hong Jiang
  • , Jia Shi
  • , Xin Shi
  • , Sijiao Liu
  • , Jinping Zhao
  • , Liyun Kong
  • , Wei Zhang
  • , Le Ma
  • Xi'an Jiaotong University
  • Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province

科研成果: 期刊稿件文献综述同行评审

73 引用 (Scopus)

摘要

Background and Aims: Associations between soy intake and risk of cancer have been evaluated in prospective observational studies with inconsistent results. Whether the potential anticancer effects offered by soy were attributed to soy isoflavones and soy protein still needs to be elucidated. This study aimed to comprehensively quantify the association of soy, soy isoflavones and soy protein intake with risk of cancer incidence and cancer mortality by conducting a meta-analysis of all available studies. Methods: PubMed, Embase, Web of Science, and Cochrane Library databases were searched up to 16 September 2021. Prospective cohort studies that examined the effect of soy, soy isoflavones and soy protein on cancer incidence and cancer mortality were identified. Random-effects models were used to pool the multivariable-adjusted relative risks (RRs) and corresponding 95% confidence intervals (CIs). The potential dose-response relations were explored by using generalized least-squares trend estimation. Results: Eighty one prospective cohort studies were included in the meta-analysis. A higher intake of soy was significantly associated with a 10% reduced risk of cancer incidence (RR, 0.90; 95% CI, 0.83–0.96). Each additional 25 g/d soy intake decreased the risk of cancer incidence by 4%. Intake of soy isoflavones was inversely associated with risk of cancer incidence (RR, 0.94; 95% CI, 0.89–0.99), whereas no significant association was observed for soy protein. The risk of cancer incidence was reduced by 4% with each 10 mg/d increment of soy isoflavones intake. Similar inverse associations were also found for soy in relation to site-specific cancers, particularly lung cancer (RR, 0.67; 95%CI, 0.52–0.86) and prostate cancer (RR, 0.88; 95%CI, 0.78–0.99). However, high intake of soy, soy isoflavones and soy protein were not associated with cancer mortality. Conclusions: Higher intake of soy and soy isoflavones were inversely associated with risk of cancer incidence, which suggested that the beneficial role of soy against cancer might be primarily attributed to soy isoflavones. These findings support recommendations to include soy as part of a healthy dietary pattern for the prevention of cancer.

源语言英语
文章编号847421
期刊Frontiers in Nutrition
9
DOI
出版状态已出版 - 4 3月 2022

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality' 的科研主题。它们共同构成独一无二的指纹。

引用此